Cui M - Search Results

1

An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine.

Wang M, Pang Z, Wang Y, Cui M, Yao L, Li S, Wang M, Zheng Y, Sun X, Dong H, Zhang Q, Xu Y. Wang M, et al. Among authors: cui m. Front Oncol. 2021 Apr 27;11:651809. doi: 10.3389/fonc.2021.651809. eCollection 2021. Front Oncol. 2021. PMID: 33987087 Free PMC article.

2

Repression of ESR1 transcription by MYOD potentiates letrozole-resistance in ERα-positive breast cancer cells.

Zhang Q, Liu XY, Li S, Zhao Z, Li J, Cui MK, Wang EH. Zhang Q, et al. Biochem Biophys Res Commun. 2017 Oct 21;492(3):425-433. doi: 10.1016/j.bbrc.2017.08.082. Epub 2017 Aug 24. Biochem Biophys Res Commun. 2017. PMID: 28842253

3

miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer.

Yu T, Yu HR, Sun JY, Zhao Z, Li S, Zhang XF, Liao ZX, Cui MK, Li J, Li C, Zhang Q. Yu T, et al. Oncotarget. 2017 Nov 9;8(63):107134-107148. doi: 10.18632/oncotarget.22359. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291017 Free PMC article.

4

Upregulation of PITX2 Promotes Letrozole Resistance Via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells.

Xu YY, Yu HR, Sun JY, Zhao Z, Li S, Zhang XF, Liao ZX, Cui MK, Li J, Li C, Zhang Q. Xu YY, et al. Cancer Res Treat. 2019 Apr;51(2):576-592. doi: 10.4143/crt.2018.100. Epub 2018 Jul 18. Cancer Res Treat. 2019. PMID: 30025446 Free PMC article.

5

Leptin-elicited PBX3 confers letrozole resistance in breast cancer.

Pang ZY, Wei YT, Shang MY, Li S, Li Y, Jin QX, Liao ZX, Cui MK, Liu XY, Zhang Q. Pang ZY, et al. Endocr Relat Cancer. 2021 Feb 1:ERC-20-0328.R2. doi: 10.1530/ERC-20-0328. Online ahead of print. Endocr Relat Cancer. 2021. PMID: 33608482

6

Influential factors and prediction model of mammographic density among Chinese women.

Shang MY, Guo S, Cui MK, Zheng YF, Liao ZX, Zhang Q, Piao HZ. Shang MY, et al. Medicine (Baltimore). 2021 Jul 16;100(28):e26586. doi: 10.1097/MD.0000000000026586. Medicine (Baltimore). 2021. PMID: 34260538 Free PMC article.

7

The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study.

Yao L, Pang Z, Wang M, Wang M, Sun X, Cui M, Zheng Y, Li X, Dong H, Zhang Q, Xu Y. Yao L, et al. Among authors: cui m. Cancer Biol Med. 2021 Oct 12;19(5):755-67. doi: 10.20892/j.issn.2095-3941.2020.0800. Online ahead of print. Cancer Biol Med. 2021. PMID: 34633775 Free PMC article.

8

OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.

Sun X, Fu X, Xu S, Qiu P, Lv Z, Cui M, Zhang Q, Xu Y. Sun X, et al. Among authors: cui m. Int Immunopharmacol. 2021 Dec;101(Pt B):108275. doi: 10.1016/j.intimp.2021.108275. Epub 2021 Oct 21. Int Immunopharmacol. 2021. PMID: 34688153

9

Research Progress on Influencing Factors and Intervention Measures of Post-traumatic Growth in Breast Cancer Patients.

Fu X, Sun J, Wang X, Cui M, Zhang Q. Fu X, et al. Among authors: cui m. Front Public Health. 2022 Jun 21;10:927370. doi: 10.3389/fpubh.2022.927370. eCollection 2022. Front Public Health. 2022. PMID: 35801243 Free PMC article. Review.

10

A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity.

Wang Y, Wang M, Yu K, Xu S, Qiu P, Lyu Z, Cui M, Zhang Q, Xu Y. Wang Y, et al. Among authors: cui m. Cancer Biol Med. 2023 Mar 24;20(3):218-28. doi: 10.20892/j.issn.2095-3941.2022.0513. Cancer Biol Med. 2023. PMID: 36971132 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,814 results

Search Page

Filters